671 related articles for article (PubMed ID: 22491770)
21. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
22. Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review.
Nikmanesh N; Hosseini S; Mirbagheri F; Asadsangabi K; Fattahi MR; Safarpour AR; Abarghooee EF; Moravej A; Shamsdin SA; Akrami H; Saghi SA; Nikmanesh Y
Viral Immunol; 2024 Jun; 37(5):221-239. PubMed ID: 38841885
[TBL] [Abstract][Full Text] [Related]
23. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8
Çuburu N; Khan S; Thompson CD; Kim R; Vellinga J; Zahn R; Lowy DR; Scheper G; Schiller JT
Int J Cancer; 2018 Apr; 142(7):1467-1479. PubMed ID: 29159802
[TBL] [Abstract][Full Text] [Related]
25. Correlating immunity with protection for HPV infection.
Frazer I
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240
[TBL] [Abstract][Full Text] [Related]
26. Evasion of host immune defenses by human papillomavirus.
Westrich JA; Warren CJ; Pyeon D
Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of human papillomaviruses in differentiating epithelia.
Longworth MS; Laimins LA
Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
[TBL] [Abstract][Full Text] [Related]
28. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
[TBL] [Abstract][Full Text] [Related]
29. The biology and life-cycle of human papillomaviruses.
Doorbar J; Quint W; Banks L; Bravo IG; Stoler M; Broker TR; Stanley MA
Vaccine; 2012 Nov; 30 Suppl 5():F55-70. PubMed ID: 23199966
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects.
Aynaud O; Piron D; Barrasso R; Poveda JD
Sex Transm Infect; 1998 Feb; 74(1):32-4. PubMed ID: 9634298
[TBL] [Abstract][Full Text] [Related]
31. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
Yadav R; Zhai L; Tumban E
Viruses; 2019 Dec; 12(1):. PubMed ID: 31877975
[TBL] [Abstract][Full Text] [Related]
32. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
33. The host response to lesions induced by human papillomavirus.
Stanley M; Coleman N; Chambers M
Ciba Found Symp; 1994; 187():21-32; discussion 32-44. PubMed ID: 7796671
[TBL] [Abstract][Full Text] [Related]
34. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
36. The Influence of Psychological Stress on HPV Infection Manifestations and Carcinogenesis.
Lugović-Mihić L; Cvitanović H; Djaković I; Kuna M; Šešerko A
Cell Physiol Biochem; 2021 Jul; 55(S2):71-88. PubMed ID: 34242500
[TBL] [Abstract][Full Text] [Related]
37. Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry.
Ozbun MA
Papillomavirus Res; 2019 Jun; 7():188-192. PubMed ID: 30981651
[TBL] [Abstract][Full Text] [Related]
38. Expression of different L1 isoforms of
Fu Y; Cao R; Schäfer M; Stephan S; Braspenning-Wesch I; Schmitt L; Bischoff R; Müller M; Schäfer K; Vinzón SE; Rösl F; Hasche D
Elife; 2020 Aug; 9():. PubMed ID: 32746966
[TBL] [Abstract][Full Text] [Related]
39. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
40. Emerging human papillomavirus vaccines.
Christensen ND
Expert Opin Emerg Drugs; 2005 Feb; 10(1):5-19. PubMed ID: 15757400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
